Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.110
+0.020 (1.83%)
At close: Mar 6, 2026, 4:00 PM EST
1.106
-0.004 (-0.36%)
After-hours: Mar 6, 2026, 7:58 PM EST
Humacyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 214 | 650 | 294 | 218 | 747 | 131 | |
| Market Cap Growth | -55.60% | 120.90% | 35.19% | -70.86% | 471.21% | - | |
| Enterprise Value | 246 | 709 | 251 | 97 | 549 | - | |
| Last Close Price | 1.11 | 5.05 | 2.84 | 2.11 | 7.25 | 10.17 | |
| PS Ratio | 136.36 | - | - | 139.03 | 591.27 | 87.68 | |
| PB Ratio | - | -12.34 | 21.72 | 1.86 | 6.11 | 1.85 | |
| P/TBV Ratio | - | - | 21.72 | 1.86 | 6.11 | - | |
| EV/Sales Ratio | 156.40 | - | - | 61.82 | 434.31 | - | |
| Debt / Equity Ratio | -10.73 | -1.54 | 4.29 | 0.43 | 0.42 | 0.41 | |
| Net Debt / Equity Ratio | -6.63 | -0.69 | -1.65 | -0.87 | -1.43 | -0.16 | |
| Net Debt / EBITDA Ratio | -0.32 | -0.34 | 0.25 | 1.33 | 2.39 | 0.20 | |
| Net Debt / FCF Ratio | -0.30 | -0.36 | 0.30 | 1.40 | 2.14 | 0.20 | |
| Asset Turnover | 0.02 | - | - | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 0.80 | 2.25 | 4.36 | 7.76 | 20.42 | 3.57 | |
| Current Ratio | 1.62 | 2.40 | 4.51 | 7.88 | 20.76 | 3.69 | |
| Return on Equity (ROE) | - | - | -169.81% | -10.01% | -27.46% | -65.58% | |
| Return on Assets (ROA) | -63.44% | -53.74% | -36.44% | -21.54% | -25.81% | -29.32% | |
| Return on Capital Employed (ROCE) | -158.80% | -97.00% | -88.30% | -45.80% | -29.50% | -67.70% | |
| Earnings Yield | -17.26% | -22.88% | -37.66% | -5.50% | -3.55% | -50.88% | |
| FCF Yield | -49.67% | -15.34% | -25.70% | -33.17% | -10.90% | -42.75% | |
| Buyback Yield / Dilution | -27.11% | -14.56% | -0.36% | -157.82% | -593.25% | 71.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.